CGB — Cann Global Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -94.95% | ||
| Return on Equity | -60.88% | ||
| Operating Margin | -1642.46% | ||
Financial Summary
| Year End 30th Jun | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 3.87 | 0.6 | 1.93 | 1.49 | 0.56 | n/a | n/a | 23.74% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Cann Global Limited is a health and wellness company. The principal activities of the Company and its subsidiaries are developing, growing, cultivating and producing hemp and medicinal cannabis products, and natural food products in the health and wellness industry. Its segments include hemp and medical cannabis products, mining exploration and evaluation and corporate. Its portfolio includes Cosmeceutical, Health Foods, and Cannabinoid Medicine. The Cosmeceutical range includes the brand Fuss Pot, which is a hemp-powered skincare brand. Its Grass Roots brand delivers a range of nutritious health-focused products that anyone can add to everyday meals and snacks. Its Grass Roots range includes nutritionist-endorsed solutions for everyday life. Its Instacann brand combines natural cannabis extracts with pharmaceutical formulations. Instacann’s tablets offer an alternative to other medicinal cannabis formats, through the use of a self-micro emulsifying drug delivery system (SMEDDS).
Directors
- David Austin NEC
- Sholom Feldman CEO
- Marion Lesaffre COO
- Franc Zvonar DSL
- Alex Neuling SEC
- Meyer Gutnick NED
- Paul Stephenson NED
- Jonathan Cohen NID
- John Easterling NID
- Last Annual
- June 30th, 2022
- Last Interim
- June 30th, 2022
- Incorporated
- April 12th, 2007
- Public Since
- January 14th, 2008
- No. of Shareholders
- 11,062
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 258,873,557
- Address
- Level 21, 133 Castlereagh Street, SYDNEY, 2000
- Web
- https://www.canngloballimited.com
- Phone
- +61 292919000
- Auditors
- Nexia Sydney Partnership
Upcoming Events for CGB
Similar to CGB
Acrux
Australian Stock Exchange - SEATS
AFT Pharmaceuticals
Australian Stock Exchange - SEATS
Althea group
Australian Stock Exchange - SEATS
Auscann group
Australian Stock Exchange - SEATS
Biome Australia
Australian Stock Exchange - SEATS
FAQ
As of Today at 18:05 UTC, shares in Cann Global are trading at AU$0.02. This share price information is delayed by 15 minutes.
Shares in Cann Global last closed at AU$0.02 and the price had moved by -79% over the past 365 days. In terms of relative price strength the Cann Global share price has underperformed the ASX All Ordinaries Index by -80% over the past year.
There is no consensus recommendation for this security.
Cann Global does not currently pay a dividend.
Cann Global does not currently pay a dividend.
Cann Global does not currently pay a dividend.
To buy shares in Cann Global you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.02, shares in Cann Global had a market capitalisation of .
Here are the trading details for Cann Global:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: CGB
Based on an overall assessment of its quality, value and momentum Cann Global is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cann Global. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -45.37%.
As of the last closing price of AU$0.02, shares in Cann Global were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Cann Global PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.02.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Cann Global's management team is headed by:
- David Austin - NEC
- Sholom Feldman - CEO
- Marion Lesaffre - COO
- Franc Zvonar - DSL
- Alex Neuling - SEC
- Meyer Gutnick - NED
- Paul Stephenson - NED
- Jonathan Cohen - NID
- John Easterling - NID